Top Pharmaceuticals Companies in Australia

The pharmaceutical industry is a critical contributor to Australia's healthcare system and economy. In 2022, the pharmaceuticals industry contributed around AUD $30 billion to the country's GDP, making up around 1.2% of the total GDP. The industry also employed over 26,000 people, making up around 0.2% of the total employment in the country. In this article, we will explore the key statistics, factors contributing to its growth and success, each industry's growth and comparison to previous years, and key trends, including technological disruptions, challenges, and future outlook.

read full article below
Filter bySearch by company name, registration number or domain name
CompanyHeadcountContactDescriptionDecision Maker
PHARMACARE LABORATORIES349 +61 2 9997 1466
customerservice@pharmacare.com.au

PharmaCare is one of the largest Australian-owned health, wellness and consumer goods companies in the country. An Australian-born and built success story, PharmaCare is dedicated to enriching people’s lives through improved health and wellness. Despite its products being available globally, its soul is Australian, its quality is Australian, and its spirit of honesty, hard work and entrepreneurial drive is Australian. PharmaCare’s trusted, household brands include Sambucol, Nature’s Way, Bioglan, Medi+, Ease-a-Cold, Skin Doctors, KP24, Brut, Norsca and many more. Our global wheelhouse of brands is available in 40 countries, over 5,200 pharmacies, 3,000 supermarkets, plus department and variety stores all over Australia, New Zealand, Asia, The Americas and Europe.

NORTHLINE347 +61 1300 722 534
customer.service@northline.com.au

Northline is an experienced Australian-based, global logistics business with an industry-leading national network and an international reach into more than 100 countries. We were founded in 1983 to service remote communities in Northern Australia and these early challenges shaped Northline and helped establish our values, build trust and form valuable partnerships that still exist to this day. Today, we provide a global, personalised service that connects our customers with their customers right across the world. Our international network transports, stores, tracks and delivers freight, by road, rail, sea and air across the globe and seamlessly connects into our national network, and modern operating facilities. We have 18 depots across Australia with the ability and flexibility to tailor solutions to meet our customers’ requirements and evolving market demands, including scaling up to add further capacity as needed. Investments in new, market leading technologies mean that Nor…

INOVA PHARMACEUTICALS565 +65 6340 3540
b.dev@inovapharma.com

iNova Pharmaceuticals develops and markets a range of over-the-counter and prescription medicines to Australasia, Asia-Pacific, South Africa and other international markets. Our focus is to improve human health and well-being by providing valued pharmaceutical products and services to patients and consumers. Our product portfolio includes weight management, pain management, dermatology, cardiology, respiratory health and allergy. At iNova our purpose is simple: deliver quality products to our patients, consumers and customers. We have a diverse portfolio of iconic brands, and dedicated employees who put peoples health first across 20 countries including Australia & New Zealand, Asia Pacific and South Africa. With a renewed vision, and an energetic and passionate focus, we are a little bit different and proud of what we do. We want you to join us in our pursuit of healthy living. Our employees work in a wide range of fast-paced, exciting environments - environments that offer continu…

ARROTEX PHARMACEUTICALS291 +61 1800 195 055
patient.safety@arrotex.com.au

Arrotex Pharmaceuticals is the largest by volume, and most diverse, pharmaceutical company in Australia. We are passionate about our mission to improve health outcomes for all Australians. We do this by working alongside community pharmacy to provide patients with affordable access to more than 400 medicines and over 250 consumer products, as well as a number of health and wellness programs. It is our values of innovation, collaboration, accountability, integrity and perseverance that focus our efforts on achieving this mission. Arrotex was formed in July 2019, following the merger of Arrow Pharmaceuticals (Arrow) and Apotex Australia (Apotex).

ACTION WORKFORCE277 +61 8 8943 0644
adminqld@actionworkforce.com.au

Action Workforce, a prominent labour hire provider, is the founding company established in 1968 within the Ashley Services Group (ASX:ASH). Today, Action Workforce is a trusted and respected partner to the industrial sector with a strong presence in the warehouse, logistics, FMCG, food, pharmaceutical, manufacturing and trades industries across Australia.

LIPA PHARMACEUTICALS LIMITED164 +61 2 8796 1400
info@lipa.com.au

Lipa Pharmaceuticals is Australia’s leading, full service, integrated, contract manufacturer of dietary supplements and OTC pharmaceutical products. At the present time Lipa is an organisation operating out of a modern, TGA, APVMA, FDA and ANVISA approved facility employing some 300 people, servicing the vast bulk of Australia’s leading brands and various overseas customers across North and South America, Europe, Asia and the Pacific region. Our success and reputation has been built on providing our customers with outstanding customer service, quality and value. This comprehensive approach to customer service allows many of our customers to focus on growing their brands and businesses both locally and internationally. At Lipa we are always on the lookout for talented people to join our business. To view current employment opportunities, please check on our ‘Jobs’ tab. Please note - Lipa only uses Australian verified recruitment platforms

SYNERTEC138 +61 3 9274 3000
info@synertec.com.au

Synertec is a diversified Technology and Engineering company focussed on developing and delivering environmentally sustainable solutions for challenging industry sectors, with particular proficiency in energy, water, critical infrastructure, advanced manufacturing, and highly regulated industries. Our Technology division focusses our design and development activity on the global energy sector to deliver technologies that increase the profitability of our partners while reducing their environmental footprint. Our Engineering division provides specialist multi-discipline engineering services to our clients through all stages of a project lifecycle and across a range of disciplines including highly specialised areas such as automation, control, monitoring, systems, process, signalling, safety, and more. In recognition of the vital importance of the issues and challenges facing the world today, Synertec has embraced an Environmental, Social, and Governance (ESG) framework and are commit…

SEFAR FILTRATION (OCEANIA)63 +61 2 8822 1700
saleswa@sefar.com

Sefar - The Worlds Filtration Expert. We are the global leader in manufacturing of customer-tailored solutions in filtration and separation, for industrial applications. Through our complete range of filtration solutions and profound technical knowledge, we are dedicated in our offering of designed tailored industrial filtration solutions that minimize downtime, in order to maximize efficiency and effectiveness of our customer fluid processes management through a Total Cost of Ownership Approach. We support our customer through a strong technical knowledge based on innovation, quality and customized solutions, leveraging on our core integrity values. Leveraging on our global experience, we design and provide tailored filtration solutions in a wide variety of applications such as: ✔️ Minerals ✔️ Food ✔️ Chemicals ✔️ Life Science ✔️ Environmental in order to assist our customers with any of their requirements. We also have developed a unique and tailored range of high quality l…

PROBIOTEC LIMITED123 +61 3 9278 7555
info@probiotec.com.au

Probiotec Limited is an ASX listed, fully Australian owned business leading the way in both contract manufacturing and packing services. As one of Australia’s largest full-service contract manufacturers, we provide best in class marketing, and distribution of diverse, high quality prescription and over-the-counter pharmaceuticals, complementary medicines, human nutrition, and specialty ingredients products. With multiple sites across Australia including Multipack LJM, South Pack Laboratories, ABS, LJM and Probiotec Pharma, the business is also one of Australia’s largest packing companies, offering a multitude of packing services – including primary, secondary & co-packing capabilities as an end-to-end manufacturing and packing partner. As a leader in Australian manufacturing and packing services, Probiotec provides innovative healthcare products that improve the lives and wellbeing of our customers.

HENNING HARDERS107 +61 3 9335 5644
rfischer@harders.com.au

Henning Harders has over 30 years’ experience as an International Freight Forwarder and Licensed Customs Broker. Family-owned and operated, we focus on enhancing our customers’ business performance in the areas of logistics and distribution, transportation, freight, customs brokerage and consulting. We have the expertise and resources to provide for the total supply chain needs of our customers worldwide. Whether it’s door-to-door service, air freight, sea freight, cold chain logistics, consolidation services, customs brokerage and clearance, warehousing or cargo insurance, Henning Harders is committed to helping our customers optimise their supply chain, improve service and achieve ROI. Looking to get your business on the move? Get in touch with our friendly team today. http://www.harders.com.au/contact-us/henning-harders-locations/

PROCHEM PIPELINE PRODUCTS PTY LTD54 +61 1300 287 777
sales@prochem.com.au

Prochem Pipeline Products Pty Ltd is a leading supplier of quality piping products, mechanical instrumentation and specialty valving solutions in Australia and New Zealand. Our company services clients nationwide to provide product engineered solutions across various fields including instrumentation, valves, piping and designing specialist solutions for unique markets. For more than 60 years, we have consistently delivered quality management, expert technical support and a total commitment to our valued customers. We value our people and encourage the development of talented and motivated employees to support the continued performance and growth of our company. We strive to build a sense of purpose and achievement among all our people in the work we do. Our values are: Passion to Perform Trust to Act Act Responsibly Make it Fun Inclusion and diversity are at our core. We are committed to fostering a culture where you can bring your whole self to work. We attract, employ and dev…

CANN GROUP87 +61 3 9095 7088
contact@canngrouplimited.com

Cann Group (ASX:CAN) is Australia’s first commercially licensed medicinal cannabis cultivator and manufacturer. We supply PIC/S GMP certified, high-THC dried flower as both API and finished product, and a range of extracts and oral oils, to our B2B customers in Australia, Germany and the UK. And our patented micro-encapsulated CBD capsules are available throughout the world under the Satipharm brand. The first stage of our new, state-of-the-art facility in regional Victoria is fully operational, with in-house analytical chemistry and microbiology laboratories, and the capacity to produce 12,500kg of high-quality flower per year, with subsequent stages planned in response to growing demand. We have extensive R&D collaborations with globally renowned agricultural and pharmaceutical research partners, and have developed our own exclusive, proprietary lines of high-yielding cultivars. Cann Group is committed to the future of high-quality, low-cost cannabis medicines, and the development …

SEERPHARMA47 +61 3 9897 1990
solutions@seerpharma.com

ADVANCING QUALITY AND GMP BEST PRACTICES IN THE ASIA-PACIFIC REGION Consulting | Training | MasterControl | Contracting SeerPharma is a team of consultants that provide best-practice advice, training, software solutions from MasterControl, and contract labour resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region on matters of Quality and GMP compliance. We have been serving our clients in the Asia-Pacific region for over 30 years from Melbourne, Sydney and Singapore and are also able to provide assistance in Europe through our affiliate in the UK. Our team of consultants has extensive experience working with clients supplying, or looking to enter the supply chain of a therapeutic product. We work with organisations looking to ensure that their facilities, equipment, quality systems and processes are compliant with FDA, PIC/S, TGA, WHO, ISO, ICH and other regulations and standards that apply to their product(s). Our consultants actively tra…

BRE SERVICES52 +61 3 9466 2601
admin@breservices.com.au

WHO WE ARE BRE Services is a business based on a passion for high quality service, building capability and customer loyalty. We have grown with our customer base through specialized services, technology and contractor demands. Our clients, and our business success, rely on our ability to be efficient, responsive and adhere to client requirements on a 24/7 basis. We care about our business, and therefore all of our clients. We have earned a reputation for achieving innovative, high quality results by providing responsive and consistent service, expert skills and sound execution capabilities providing industrial electrical services. Our head office is situated in Thomastown, Melbourne and we have workshops in both Thomastown and Dandenong South, with a team of over 150 based all over Melbourne, allowing us to provide efficient response to our clients across the northern, eastern and western suburbs. We also have customers in regional areas throughout Victoria, and also provide national…

PHARMAXIS73 +61 2 9454 7200
med.info@pharmaxis.com.au

Pharmaxis Ltd is an Australian pharmaceutical research company developing drugs for inflammatory and fibrotic diseases, with a focus on myelofibrosis. The company has a highly productive drug discovery engine built on its expertise in the chemistry of amine oxidase inhibitors, with drug candidates in clinical trials. Pharmaxis has also developed two respiratory products which are approved and supplied in global markets, generating ongoing revenue. Pharmaxis is developing its drug PXS-5505 for the bone marrow cancer myelofibrosis which causes a build up of scar tissue that leads to loss of production of red and white blood cells and platelets. The US Food and Drug Administration has granted Orphan Drug Designation to PXS-5055 for the treatment of myelofibrosis and permission under an Investigational Drug Application (IND) to progress a phase 1c/2 clinical trial that is scheduled to begin recruitment in Q1 2021. PXS‐5505 is also being investigated as a potential treatment for other can…

INSERVIO61 +61 1300 803 901
privacy@inservio.com.au

Inservio is a dynamic patient services organisation, full of vibrant and passionate people who are determined to support better outcomes for patients. Established more than 15 years ago, our mission has continued to make lives easier for patients. Inservios unique structure and operation allows us to provide a range of services tailored to patients treatment needs. Our services extend across a range of therapeutic areas including ophthalmology, immunological diseases, pulmonary arterial hypertension, cancer, spinal muscular atrophy, respiratory diseases and many more.

MEDLAB CLINICAL LTD19 +61 2 8188 0311
hello@medlab.co

Medlab Clinical Ltd is an Australian, publicly listed biotechnology company (ASX:MDC) developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas including pain management, mental health, gut health, diabetes, and allergies. We fabricate remarkable pharmaceuticals that triumph against current market competition. Through our talented managerial and scientific teams, we furnish our brand warrant - to provide practitioners with innovative, evidence based products they can confidently prescribe. At Medlab Clinical Ltd, we believe that all of our employees have the fundamentals to be phenomenal. Where innovative thinking thrives and people are valued. We believe that assessing our business´s performance is an important step to ensure a reputation as marketplace leaders. …

AUSTRALIAN DOCTOR GROUP40 +61 2 8484 0666
customerservice@adg.com.au

As the number one independent medical platform, for over 35 years ADG, through Australian Doctor and its other leading brands, have kept doctors informed with independent news, opinion, clinical features and CPD-accredited education. Why is this important? We believe doctors are one of the cornerstones of the Australian health system, and recognise that quality care is a major determinant of the health & wellbeing of a society. We acknowledge the challenges faced by doctors, and use our voice to enhance the work and lives of all doctors and their patients. By harnessing the combined knowledge and commitment of the medical and pharmaceutical community, and building on a foundation of trust and knowledge, we believe in enabling and empowering healthcare professionals to provide the best healthcare and practice great medicine to help Australians live healthier, longer lives.

CLINUVEL PHARMACEUTICALS LTD54 +61 3 9660 4909
safety@clinuvel.com

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population. As pioneers in photomedicine and understanding the interaction of light and human biology, CLINUVEL’s research and development has led to innovative treatments for patient populations with a clinical need for systemic photoprotection, DNA repair and acute or life threatening conditions. These patient groups range in size from 5,000 to 45 million worldwide. CLINUVEL’s lead compound, SCENESSE® (afamelanotide 16mg), was approved by the European Commission in 2014 and the US Food and Drug Administration in 2019 for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). More information …

ACURABIO49 +61 7 3273 9176
enquiries@acurabio.com

AcuraBio (formerly Luina Bio) is one of Australia’s most experienced biologics CDMOs, conveniently located in Brisbane, Queensland. We offer an inclusive set of services including process development and GMP manufacture of recombinant proteins, vaccines and live bio-therapeutics for human and veterinary use. We can produce material for pre-clinical studies and clinical trial GMP batches for Phase 1, 2 and 3 clinical studies. We have more than 20 years of contract manufacturing experience with a dedicated team of highly educated and trained personnel. We have worked with Australian, European, American and Asian clients supporting their development needs. We maintain a TGA/APVMA/OGTR inspected and approved facility that offers optimum flexibility to keep your development rate fast and your costs low while ensuring quality is never compromised.

Top Pharmaceuticals Companies in Australia

Factors Contributing to the Growth and Success of the Pharmaceuticals Industry

The growth and success of the pharmaceutical industry in Australia can be attributed to several factors. One of the most significant factors is the country's strong healthcare system, which is supported by a well-funded public health system and a robust private healthcare sector. This has created a favorable environment for the industry to thrive.

Another factor contributing to the growth of the pharmaceutical industry is the government's focus on healthcare. The government has taken several initiatives to improve access to healthcare, such as increasing funding for research and development and improving the regulatory framework for pharmaceuticals.

Growth and Comparison of Each Industry in the Pharmaceuticals Sector

The pharmaceutical industry in Australia comprises several sub-sectors, including research and development, manufacturing, and distribution. The research and development sector is the largest sub-sector, accounting for around 60% of the industry's total revenue, followed by manufacturing (25%) and distribution (15%).

In 2022, the research and development sector in Australia saw a decline in revenue due to reduced demand caused by the pandemic. The manufacturing and distribution sectors also saw a decline in revenue due to supply chain disruptions and reduced demand.

Key Trends, including Technological Disruptions

The pharmaceutical industry is continuously evolving, and several technological disruptions are changing the way businesses operate. One of the most significant technological disruptions is the adoption of digital technologies such as artificial intelligence (AI), the Internet of Things (IoT), and blockchain. These technologies have the potential to transform almost every industry, enabling businesses to become more efficient, productive, and competitive.

Another key trend in the pharmaceutical industry is the increasing focus on personalized medicine. Advances in genetics and genomics are enabling healthcare providers to tailor treatments to individual patients, increasing the efficacy of treatments and reducing the risk of adverse side effects.

Challenges Facing the Pharmaceuticals Industry

Despite the growth and success of the pharmaceutical industry in Australia, it is facing several challenges. One of the most significant challenges is the increasing pressure on drug prices. Healthcare costs are rising globally, and governments are looking for ways to reduce spending on pharmaceuticals.

Another challenge facing the industry is the increasing competition. The industry is highly competitive, and companies are under pressure to develop new and innovative products to remain competitive. The increasing competition is putting pressure on profit margins and reducing the returns on investment.

Future Outlook for the Pharmaceuticals Industry

The outlook for the pharmaceutical industry in Australia is positive. The industry is expected to continue to grow, driven by the increasing demand for healthcare services, advances in technology, and government initiatives aimed at improving access to healthcare.

To sustain this growth, the industry will need to address the challenges it faces, such as the increasing pressure on drug prices and competition. The industry must also keep up with the pace of technological change and ensure that businesses are equipped to take advantage of new technologies.

Conclusion

In conclusion, the pharmaceutical industry in Australia has been a significant contributor to the country's economic growth and development. The industry has been driven by the country's strong healthcare system and the government's focus on healthcare. The industry comprises several sub-sectors, including research and development, manufacturing, and distribution.

The industry is facing several challenges, including increasing pressure on drug prices and competition. However, the future outlook for the industry is positive, and it is expected to continue to grow and evolve in the coming years. The industry's success will depend on its ability to address the challenges it faces and stay at the forefront of technological change.

One potential avenue for growth in the pharmaceutical industry is through partnerships and collaborations with other businesses and organizations. This can help companies to access new markets, technologies, and expertise while also reducing risk and sharing costs.

undefined's picture
By Melissa Goh
Published on 11 May 2023